173 related articles for article (PubMed ID: 37078789)
1. In vitro comparative study of multimodal imaging nano-assembled microspheres with two clinical drug-eluting beads loaded with doxorubicin.
He Y; Xu T; Ding T; Gong Y; Zeng H; Xi Z; Ye Y; Song Z; Pan T; Zhang Z; Ma Q; Li L; Zhang Y; Shao G
Drug Deliv; 2023 Dec; 30(1):2197177. PubMed ID: 37078789
[TBL] [Abstract][Full Text] [Related]
2. CalliSpheres Drug-Eluting Bead Transcatheter Arterial Chemoembolization Presents With Better Efficacy and Equal Safety Compared to Conventional TACE in Treating Patients With Hepatocellular Carcinoma.
Xiang H; Long L; Yao Y; Fang Z; Zhang Z; Zhang Y
Technol Cancer Res Treat; 2019 Jan; 18():1533033819830751. PubMed ID: 30862264
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Triple-Drug Transcatheter Arterial Chemoembolization (TACE) With Single-Drug TACE Using Doxorubicin-Eluting Beads: Long-Term Survival in 313 Patients.
Gomes AS; Monteleone PA; Sayre JW; Finn RS; Sadeghi S; Tong MJ; Britten CD; Busuttil RW
AJR Am J Roentgenol; 2017 Oct; 209(4):722-732. PubMed ID: 28705059
[TBL] [Abstract][Full Text] [Related]
4. Multimodal imaging of nano-assembled microspheres loaded with doxorubicin and Cisplatin for liver tumor therapy.
He Y; Zhang Y; Gong Y; Zhang Z; Xu T; Tian L; Pan T; Yang H; Pan H; Kou Q; Wang H; Shao G
Front Bioeng Biotechnol; 2022; 10():1024174. PubMed ID: 36213082
[TBL] [Abstract][Full Text] [Related]
5. Composition-property relationships for radiopaque composite materials: pre-loaded drug-eluting beads for transarterial chemoembolization.
Kilcup N; Tonkopi E; Abraham RJ; Boyd D; Kehoe S
J Biomater Appl; 2015 Jul; 30(1):93-103. PubMed ID: 25690386
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of drug-eluting bead-transcatheter arterial chemoembolization using 100-300 μm versus 300-500 μm CalliSpheres microspheres in patients with advanced-stage hepatocellular carcinoma.
Yang T; Qin W; Sun X; Wang Y; Wu J; Li Z; Ji F; Zhang L; Liu W
J Cancer Res Ther; 2020; 16(7):1582-1587. PubMed ID: 33565503
[TBL] [Abstract][Full Text] [Related]
7. DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization.
Lewis AL; Gonzalez MV; Lloyd AW; Hall B; Tang Y; Willis SL; Leppard SW; Wolfenden LC; Palmer RR; Stratford PW
J Vasc Interv Radiol; 2006 Feb; 17(2 Pt 1):335-42. PubMed ID: 16517780
[TBL] [Abstract][Full Text] [Related]
8. CalliSpheres drug-eluting beads versus lipiodol transarterial chemoembolization in the treatment of hepatocellular carcinoma: a short-term efficacy and safety study.
Wu B; Zhou J; Ling G; Zhu D; Long Q
World J Surg Oncol; 2018 Mar; 16(1):69. PubMed ID: 29587773
[TBL] [Abstract][Full Text] [Related]
9. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics.
Varela M; Real MI; Burrel M; Forner A; Sala M; Brunet M; Ayuso C; Castells L; Montañá X; Llovet JM; Bruix J
J Hepatol; 2007 Mar; 46(3):474-81. PubMed ID: 17239480
[TBL] [Abstract][Full Text] [Related]
10. Preparation of Radiopaque Drug-Eluting Beads for Transcatheter Chemoembolization.
Johnson CG; Tang Y; Beck A; Dreher MR; Woods DL; Negussie AH; Donahue D; Levy EB; Willis SL; Lewis AL; Wood BJ; Sharma KV
J Vasc Interv Radiol; 2016 Jan; 27(1):117-126.e3. PubMed ID: 26549370
[TBL] [Abstract][Full Text] [Related]
11. In vitro characterization of immune modulating drug-eluting immunobeads towards transarterial embolization in cancer.
Negussie AH; Mikhail AS; Owen JW; Hong N; Carlson CJ; Tang Y; Carrow KP; Mauda-Havakuk M; Lewis AL; Karanian JW; Pritchard WF; Wood BJ
Sci Rep; 2022 Dec; 12(1):21886. PubMed ID: 36535979
[TBL] [Abstract][Full Text] [Related]
12. Transarterial chemoembolization with medium-sized doxorubicin-eluting Callisphere is safe and effective for patients with hepatocellular carcinoma.
Wang CY; Xia JG; Yang ZQ; Zhou WZ; Chen WH; Qi CJ; Gu JP; Wang Q
Sci Rep; 2020 Mar; 10(1):4434. PubMed ID: 32157110
[TBL] [Abstract][Full Text] [Related]
13. [Transcatheter arterial chemoembolization with doxorubicin eluting beads in the treatment of hepatocellular carcinoma].
Sousa PF; Preto AS; Leão D; Madureira AM; Paquete J; Costa-Maia J; Vilares-Morgado P
Acta Med Port; 2011; 24(1):29-36. PubMed ID: 21672439
[TBL] [Abstract][Full Text] [Related]
14. Drug-eluting bead transarterial chemoembolization with medium-sized versus small-sized CalliSpheres microspheres in unresectable primary liver cancer.
Zhang J; Feng GA; Li Y; Wang W
Asia Pac J Clin Oncol; 2022 Aug; 18(4):388-393. PubMed ID: 34708554
[TBL] [Abstract][Full Text] [Related]
15. [Comparative effect of CalliSpheres drug loading microspheres and lipiodol transarterial chemoembolization in the treatment of huge primary liver cancer].
Liu JF; Duan XH; Ren JZ; Jiao DC; Han XW
Zhonghua Gan Zang Bing Za Zhi; 2019 Jun; 27(6):460-462. PubMed ID: 31357764
[TBL] [Abstract][Full Text] [Related]
16. Safety, Efficacy and Distribution of Doxorubicin Loaded Radiopaque Beads in Chemoembolization in Intermediate Stage Hepatocellular Carcinoma (HCC) with Correlation with Local Response.
Malagari Κ; Kiakidis T; Moschouris H; Deutsch M; Tanteles S; Pantou E; Panagiotou I; Koskinas J; Glantzounis GK; Alexopoulou A; Filippiadis D; Brountzos E; Kelekis N
Cardiovasc Intervent Radiol; 2023 Mar; 46(3):337-349. PubMed ID: 36653660
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin eluting beads - 1: effects of drug loading on bead characteristics and drug distribution.
Lewis AL; Gonzalez MV; Leppard SW; Brown JE; Stratford PW; Phillips GJ; Lloyd AW
J Mater Sci Mater Med; 2007 Sep; 18(9):1691-9. PubMed ID: 17483878
[TBL] [Abstract][Full Text] [Related]
18. DEB TACE for Intermediate and advanced HCC - Initial Experience in a Brazilian Cancer Center.
Luz JH; Luz PM; Martin HS; Gouveia HR; Levigard RB; Nogueira FD; Rodrigues BC; de Miranda TN; Mamede MH
Cancer Imaging; 2017 Feb; 17(1):5. PubMed ID: 28166821
[TBL] [Abstract][Full Text] [Related]
19. Short-term efficacy and safety of callispheres drug-loaded microsphere embolization in primary hepatocellular carcinoma.
Li J; Wang N; Shi C; Liu Q; Song J; Ye X
J Cancer Res Ther; 2021 Jul; 17(3):733-739. PubMed ID: 34269307
[TBL] [Abstract][Full Text] [Related]
20. The effect of doxorubicin loading on response and toxicity with drug-eluting embolization in resectable hepatoma: a dose escalation study.
Klass D; Owen D; Buczkowski A; Chung SW; Scudamore CH; Weiss AA; Yoshida EM; Ford JA; Ho S; Liu DM
Anticancer Res; 2014 Jul; 34(7):3597-606. PubMed ID: 24982375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
